Jim Cramer, the host of CNBC’s “Mad Money,” is known for his energetic and often controversial takes on the stock market.

Novo Nordisk announced Phase 2a trial results for monlunabant. The trial demonstrated a weight reduction of 7.1 kg with a 10 ...

Buying $1000 In GWW: If an investor had bought $1000 of GWW stock 5 years ago, it would be worth $3,534.58 today based on a ...

Mullen team present in Dubai this week for delivery of first EV vehicles. Mullen recently executed a 1-for-100 reverse stock ...

Gartner IT has outperformed the market over the past 15 years by 13.06% on an annualized basis producing an average annual ...

The union members, most of them based in Washington state, turned down a proposal to raise wages by 25% over four years, as ...

Sable Offshore shares are trading lower by 21% Friday afternoon. The company announced a $150 million private placement.

FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic ...

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...

Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose.

According to the Your Money Retirement Survey conducted by SurveyMonkey and CNBC.com, about 37% of workers – including those ...

Onchain analytics firm Lookonchain identified an Ethereum (CRYPTO: ETH) whale losing $13 million in the past six months as ...